Status:
UNKNOWN
Battlefield Acupuncture With Sodium Hyaluronate Injections
Lead Sponsor:
Brooke Army Medical Center
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The study evaluates pain relief and subsequent range of motion changes combining battlefield acupuncture with sodium hyaluronate vs local anesthetic and sodium hyaluronate
Detailed Description
Sodium hyaluronate is FDA approved for knee osteoarthritis. It is a widely used treatment for this condition. This does provide immediate pain relief and is often used in conjunction with lidocaine an...
Eligibility Criteria
Inclusion
- Patients of the BAMC Orthopaedic clinic
- Active duty, dependent and civilians
- Ages 18-65
- Diagnosed with knee osteoarthritis by their Orthopaedic provider
- Determined to be eligible for Sodium Hyaluronate injections by their Orthopaedic provider
Exclusion
- Patient without knee osteoarthritis diagnosis
- Patient requiring immediate surgery for their knee complaints
- Patients younger than 18 or older than 65
- Pregnant patients
- Patients without active pain
- Patients with history of knee arthroplasty
- Patients with auricular deformity which would affect BFA
- Patient with history of vasovagal secondary to needles or injections
- Patients with active infection at BFA treatment sites
Key Trial Info
Start Date :
February 23 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03456011
Start Date
February 23 2018
End Date
January 31 2019
Last Update
March 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BAMC
Fort Sam Houston, Texas, United States, 78234